Search

Phase 3 Study Results Demonstrated Three Year, Disease-Free Survival of 96% THOUSAND OAKS, Calif., Dec. 7, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new data demonstrating that adding BLINCYTO(blinatumomab) to [...]

MITIGATE Phase 3 Study Results Reinforce Promise of UPLIZNA as the First Potential Treatment tor IgG4-RD Phase 4 AGILE Data Support Shortening KRYSTEXXA Infusion Time THOUSAND OAKS, Calif., Nov. 14, [...]

MINT Study Results Show Clinically Meaningful and Statistically Significant Efficacy in AChR+ and MuSK+ Patients First and Only Phase 3 Placebo-Controlled gMG Trial for a Biologic That Tapered Corticosteroid Use [...]

Ottawa, July 30, 2024 (GLOBE NEWSWIRE) -- The global https://www.globenewswire.com/Tracker?data=_jLWpXTrUqaEcI6zCvBKiTEPdGlpCubjaObXaGm37ucJXGUkHmzwQgxJ9T5Tz5Oz7V6dJvelwOVVIJT2mCsqJhz9uZ4_3HwNl8OOExhSu4M27-eRnWX6J7e3-QK3cYc1rXS4xVeD_Pyx2HodFE7hQ9H0aykXgvwK3Gc1veibJGo= size is predicted to grow from USD 5.45 billion in 2023 to approximately USD 38.08 billion by 2033, a study [...]

M2 PRESSWIRE-June 19, 2024-: Immune Checkpoint Inhibitors Market to Grow at a decent CAGR during the Study Period by DelveInsight | Fianlimab (REGN-3767), Cobolimab (GSK-4069889), Tiragolumab (RG-6058), Ezabenlimab, etc (C)1994-2024 [...]

BLINCYTO Added to Multiphase Consolidation Chemotherapy Reduced Risk of Death by 58% Showing Superior Overall Survival Versus Chemotherapy Alone First and Only Bispecific T-cell Engager (BiTE) Therapy for Consolidation Treatment [...]

Data Show a Statistically Significant 87% Reduction in IgG4-RD Flares, With Primary and All Key Secondary Endpoints Met First Randomized, Placebo-Controlled Trial to Demonstrate Benefit in IgG4-RD THOUSAND OAKS, Calif., [...]

In ongoing dose escalation, CNTY-101 has demonstrated a manageable safety profile with no observed DLTs or GvHD and with majority of patients treated in outpatient setting Encouraging preliminary efficacy in [...]

Research antibodies used in scientific research help us understand how cells and molecules work in different areas of life sciences. The worldwide market for these research antibodies is predicted to [...]

M2 PRESSWIRE-February 8, 2024-: Sjogren's Syndrome Market Poised for Phenomenal Expansion During the Forecast Period (2023-32) - DelveInsight | Gilead, Daiichi Sankyo, Bayer, Vielabio, Remegen, Pfizer, Novartis, Genentech (C)1994-2024 M2 [...]

SEATTLE, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced the U.S. Food and [...]

Wilmington, Delaware, United States, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global anticancer drugs market was projected to attain US$ 140.2 billion in 2022. It [...]

Multiple Investigator Sponsored Studies Support the Potential of BLINCYTO(blinatumomab) Across Acute Lymphoblastic Leukemia Treatment Paradigm New Data Reinforce KYPROLIS(carfilzomib) as an Important Treatment Option for Relapsed or Refractory Multiple Myeloma [...]

- Represents second IND clearance for CNTY-101, the Company's lead iPSC-derived CD19-targeted CAR NK cell product candidate, and first in an autoimmune and inflammatory disease indication - - Company plans [...]

B-cell lymphoma, a subtype of non-Hodgkin lymphoma, stands as the leading cancer diagnosis in the United States, comprising 85% of all cases. This cancer targets the lymphatic system, encompassing lymph [...]

Phase 1 trial to investigate multiple B-cell mediated autoimmune diseases First healthy donor-derived allogeneic CAR T cell therapy to announce IND clearance Expect to disclose initial clinical data next year [...]

PDS0202 (Infectimune [sup. (R) ] + COBRA influenza antigens) vaccination also prevented illness/weight loss Vaccine protected against replication of the virus in the lungs of ferrets after challenge with the [...]

LOS ANGELES, Aug. 25, 2023 (GLOBE NEWSWIRE) -- The https://www.globenewswire.com/Tracker?data=YQe1dyYK3aQTqqFGDwoCwYADITMC6xKN1KNqTmrD-OBRDistX5omBkuAPsKmkPDW1sTEkxLhYEU5DUq6XVA2L_c4ue52tdcD_a9GPla_DqRWyKiWu-NKIf1IDFGp9ZUJEEl4JyrwVcZrrAROKhDCSumefOqlO735KL4fLYU7SUQ= outlook remains positive, fueled by rising disease incidence, increasing pharma R&D investments, growing biotechnology research funding, and advancements in recombinant [...]

M2 PRESSWIRE-June 20, 2023-: Diffuse Large B-Cell Lymphoma Market expected to rise | Companies - AbbVie and Genmab, Merck, Roche, Xencor and Janssen, Denovo Biopharma, Calithera Biosciences, IMV, Biogen, Autolus [...]

DUBLIN, June 15, 2023 /PRNewswire/ -- The https://www.researchandmarkets.com/reports/3502817/cell-surface-markers-global-strategic-business?utm_source=CI&utm_medium=PressRelease&utm_code=m9wm9c&utm_campaign=1860893+-+Global+Cell+Surface+Markers+Analysis+Report+2023%3a+High+Uptake+in+Drug+Discovery+Applications+Widens+Market+Prospects+-+Forecasts+to+2030&utm_exec=chdo54prd report has been added toResearchAndMarkets.com's offering. Global Cell Surface Markers Market to Reach $1.5 Billion by 2030 The global market for Cell [...]

The dynamics of the immune checkpoint inhibitors market are expected to change in the coming years owing to the rising cancer cases, increasing healthcare spending across the globe, and the [...]

M2 PRESSWIRE-April 24, 2023-: Diffuse Large B-Cell Lymphoma Pipeline Report Provides the Assessment of Mono and Combination Therapies by Stage | Major Companies - Roche, Genentech, AbbVie, and Others (C)1994-2023 [...]

M2 PRESSWIRE-April 24, 2023-: T-Cell Lymphoma Pipeline Assets and Comparative Analysis of Clinical and Non-Clinical Stage Products | Major Companies - Jazz Pharmaceuticals, Celgene, Pfizer, and Others (C)1994-2023 M2 COMMUNICATIONS [...]

Next-generation immunotherapies market is expected to grow significantly during the forecast period (2023--2032) owing to the increasing number of cancer cases in the 7MM, accompanied by the introduction of novel [...]

M2 PRESSWIRE-April 10, 2023-: Small Lymphocytic Lymphoma Pipeline Featuring 80+ Companies Expected to Change the Pace of the Treatment | Major Companies - Pfizer, Loxo Oncology, and Others (C)1994-2023 M2 [...]

HCW Biologics Published a Pivotal Scientific Paper in Aging Cell Subcutaneous Administration of HCW9218 Systemically Reduces Senescent Cells and Alleviates Senescence-Associated Secretory Phenotype Factors in Mice MIRAMAR, Fla., April 03, [...]

New York, USA, March 30, 2023 (GLOBE NEWSWIRE) -- Propulsion of Acute Lymphocytic Leukemia Pipeline as Novel and Extensive 160+ Therapies Likely to Enter in the Treatment Domain | DelveInsight [...]

DUBLIN -- The 'Global LAG-3 Inhibitor Market, Drug Sales, Price & Clinical Trials Insight 2028' report has been added to ResearchAndMarkets.com's offering. In the last few decades, immune checkpoints have [...]

M2 PRESSWIRE-March 10, 2023-: Diffuse Large B-cell Lymphoma Pipeline Assessment of Active Pipeline Assets Segmented by Stage, Product Type, Route of Administration and Molecule Type (C)1994-2023 M2 COMMUNICATIONS RDATE:09032023 DelveInsight's, [...]

DUBLIN, March 7, 2023 /PRNewswire/ -- The https://www.researchandmarkets.com/reports/5733901/rituximab-biosimilars-global-market-report?utm_source=CI&utm_medium=PressRelease&utm_code=92889k&utm_campaign=1827719+-+Global+Rituximab+Biosimilars+Market+Report+2023%3a+Major+Players+Include+Pfizer%2c+Mylan%2c+Amgen%2c+Teva+Pharmaceutical+Industries+and+Celltrion+Healthcare&utm_exec=jamu273prd report has been added toResearchAndMarkets.com's offering. This report provides strategists, marketers and senior management with the critical information they need to assess [...]

M2 PRESSWIRE-March 2, 2023-: Rich Insights into the COVID-19 Pipeline and Clinical Trial Analysis Featuring 400+ Companies and Therapies (C)1994-2023 M2 COMMUNICATIONS RDATE:01032023 DelveInsight's, 'COVID-19 Pipeline Insight, 2023,' report provides [...]

NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Major players in the rituximab biosimilars market are Pfizer Inc., Mylan Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Celltrion Healthcare Co. Ltd., Sandoz [...]

M2 PRESSWIRE-January 31, 2023-: Diffuse Large B-Cell Lymphoma Pipeline Insight and Clinical Trials Analysis and NDA Approvals | 80+ Companies and 80+ Drugs (C)1994-2023 M2 COMMUNICATIONS RDATE:30012023 DelveInsight's, 'Diffuse Large [...]

M2 PRESSWIRE-January 31, 2023-: COVID-19 Pipeline Insight and Clinical Trial Analysis Featuring 400+ Key Companies by DelveInsight (C)1994-2023 M2 COMMUNICATIONS RDATE:30012023 DelveInsight's, 'COVID-19 Pipeline Insight, 2023,' report provides comprehensive insights [...]

M2 PRESSWIRE-January 24, 2023-: Small Lymphocytic Lymphoma Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight (C)1994-2023 M2 COMMUNICATIONS RDATE:23012023 DelveInsight's, 'Small Lymphocytic [...]

DUBLIN, Jan. 19, 2023 /PRNewswire/ -- The https://www.researchandmarkets.com/reports/5457783/market-forecasts-for-immuno-oncology-diagnostics?utm_source=CI&utm_medium=PressRelease&utm_code=d669gg&utm_campaign=1807218+-+Global+Immuno-Oncology+Diagnostics+Market+Report+2023-2028%3a+Diagnostic+Companies+and+Instrumentation+Suppliers+are+Jockeying+for+Position+in+a+New+Approach+to+Conquering+Cancer&utm_exec=chdo54prd report has been added toResearchAndMarkets.com's offering. Diagnostics, companion diagnostics, is driving the success of Immuno-oncology Therapeutics. An entire new segment of the [...]

Dublin, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The https://www.researchandmarkets.com/reports/5581821/market-forecasts-for-immuno-oncology-diagnostics?utm_source=GNOM&utm_medium=PressRelease&utm_code=62szb7&utm_campaign=1808327+-+Market+Forecasts+for+Immuno-Oncology+Diagnostics+2023%3a+Outcome+Potential+and+Companion+Diagnostics+Driving+Growth&utm_exec=como322prd report has been added to ResearchAndMarkets.com's offering. Diagnostics, companion diagnostics, is driving the success of Immuno-oncology Therapeutics. An entire new segment [...]

M2 PRESSWIRE-November 25, 2022-: Diffuse Large B-Cell Lymphoma Pipeline | 80+ Companies and 80+ Drugs | DelveInsight (C)1994-2022 M2 COMMUNICATIONS RDATE:24112022 DelveInsight's, 'Diffuse Large B-Cell Lymphoma Pipeline Insight, 2022,' report [...]

Dallas, Texas, Oct. 27, 2022 (GLOBE NEWSWIRE) -- The adoption of sedentary lifestyles that increase obesity rates and the development of chronic diseases like cancer, diabetes, and cardiovascular diseases (CVDs) [...]

Luton, Bedfordshire, United Kingdom, Sep 05, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START EQNX::TICKER_END Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has completed [...]

NEW YORK, July 27, Jul 27, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START (NasdaqGM:INAB), EQNX::TICKER_END -- All three patients from the first cohort of high-risk relapsed acute-myeloid leukemia (AML) patients [...]

New York, June 16, Jun 16, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START EQNX::TICKER_END Reportlinker.com announces the release of the report 'Global Cell Surface Markers Industry' - https://www.reportlinker.com/p05818177/?utm_source=GNW -Online interactive [...]

Dublin, April 28, Apr 28, 2022 (GLOBE NEWSWIRE via COMTEX) -- The 'The T-cell Lymphoma Market - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028' report has been added [...]

DUBLIN, April 28, 2022 /PRNewswire/ -- The https://www.researchandmarkets.com/reports/5509667/the-t-cell-lymphoma-market-size-share?utm_source=CI&utm_medium=PressRelease&utm_code=ltqh6t&utm_campaign=1690619+-+Worldwide+T-cell+Lymphoma+Industry+to+2028+-+Featuring+Genmab%2c+Seagen+and+GlaxoSmithKline+Among+Others&utm_exec=jamu273prd report has been added toResearchAndMarkets.com's offering. Lymphoma is the most common type of blood cancer which occurs when white blood cells called [...]

DUBLIN -- The 'The T-cell Lymphoma Market - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028' report has been added to ResearchAndMarkets.com's offering. Lymphoma is the most common type [...]

M2 PRESSWIRE-April 25, 2022-: Global T-cell Lymphoma Market Report to 2028 - Size, Share, Outlook, and Opportunity Analysis (C)1994-2022 M2 COMMUNICATIONS RDATE:25042022 The 'The T-cell Lymphoma Market - Size, Share, [...]

DUBLIN -- The 'Viral Vector and Plasmid DNA Manufacturing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)' report has been added to ResearchAndMarkets.com's offering The viral vector [...]

M2 PRESSWIRE-March 30, 2022-: $2.34 Billion Viral Vector and Plasmid DNA Manufacturing Markets, 2027 (C)1994-2022 M2 COMMUNICATIONS RDATE:30032022 The 'Viral Vector and Plasmid DNA Manufacturing Market - Growth, Trends, COVID-19 [...]

DUBLIN, March 28, 2022 /PRNewswire/ -- The 'Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates' report has been added toResearchAndMarkets.com's offering. Diagnostics, companion diagnostics, is driving the success [...]